Claus-Henning Koehne: the awareness of K-Ras is a great progress in molecular targeted therapy

Posted On 2014-08-19 11:56:42

Dr. Claus-Henning Koehne, Chairman of the Department of Hematology and Oncology, Klinikum Oldenburg, Germany, is an internationally renowned prolific and outstanding oncologist and hematologist. In 2012 Chinese Society of Clinical Oncology (CSCO) conference, Dr. Koehne was interviewed by Chinese Clinical Oncology (CCO) and gave a brief introduction of the achievement and limitation in molecular targeted chemotherapy, and the clinical features of aggressive disease in China and Germany.


Dr. Claus-Henning Koehne